Participant Database for Autism Research Studies

September 16, 2020 updated by: Tal Kenet, Massachusetts General Hospital

Database for Persons Interested in Research Studies of Developmental Disorders

The purpose of this study is to create a subject database to recruit for current and future studies in research on autism and other neurodevelopmental disabilities.

Study Overview

Status

Recruiting

Detailed Description

Aim 1: to recruit people interested in research on autism and other neurodevelopmental disabilities

Aim 2: to complete a diagnostic assessment, to confirm the diagnosis of autism spectrum disorder or other developmental disability (e.g., developmental language delay) in our patient population and rule out a diagnosis of autism spectrum disorder and other comorbid conditions in our control group

Aim 3: to maintain subject information in a database, from which we can recruit for our studies

Study Type

Observational

Enrollment (Anticipated)

120

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • Massachusetts
      • Charlestown, Massachusetts, United States, 02129
        • Recruiting
        • Martinos Center of Biomedical Imaging

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

14 years to 32 years (Child, Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Adult/Pediatric

Description

Inclusion Criteria:

  • Typically-developing, healthy adolescents and adults (ages 14-32)
  • Adolescents and adults with autism spectrum disorder (ages 14-32)

Exclusion Criteria:

  • Extreme premature birth (<34 weeks)
  • Known genetic disorders related to autism (e.g. Fragile X)
  • Recent diagnosis of psychosis (within 6 months)
  • Some other psychiatric diagnoses may be excluded following screening (e.g. Tourette's syndrome).
  • Metal implants / permanent retainers / hair dyes with metallic components

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Individuals with Autism Spectrum Disorder

No intervention

ASD participants ages 14-32 for a neuroimaging study.

Healthy individuals

No intervention

Healthy participants ages 14-32 for a neuroimaging study.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Tal Kenet, Ph.D, Massachusetts General Hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 1, 2013

Primary Completion (Anticipated)

June 1, 2023

Study Completion (Anticipated)

June 1, 2023

Study Registration Dates

First Submitted

October 15, 2007

First Submitted That Met QC Criteria

October 25, 2007

First Posted (Estimate)

October 26, 2007

Study Record Updates

Last Update Posted (Actual)

September 18, 2020

Last Update Submitted That Met QC Criteria

September 16, 2020

Last Verified

September 1, 2020

More Information

Terms related to this study

Other Study ID Numbers

  • 2007-P-000062
  • 5R01MH117998 (U.S. NIH Grant/Contract)

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Autism Spectrum Disorder

3
Subscribe